Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers

Author： Dias Maria   Carvalho Jesus   Rodrigues Debora   Graziani Silvia   Maranhão Raul  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.1, 2007-01, pp. : 105-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease

By Hungria Vania   Latrilha Maria   Rodrigues Debora   Bydlowski Sergio   Chiattone Carlos   Maranhão Raul  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 51-60

Springer Publishing Company

Access to resources Recommend Favorite

Uptake of a Cholesterol-Rich Emulsion by Neoplastic Ovarian Tissues

By Ades A.   Carvalho J.P.   Graziani S.R.   Amancio R.F.   Souen J.S.   Pinotti J.A.   Maranhao R.C.  

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 84-87

Elsevier

Access to resources Recommend Favorite

Uptake of a Cholesterol-Rich Emulsion by Breast Cancer

By Graziani S.R.   Igreja F.A.F.   Hegg R.   Meneghetti C.   Brandizzi L.I.   Barboza R.   Amâncio R.F.   Pinotti J.A.   Maranhão R.C.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 493-497

Academic Press

Access to resources Recommend Favorite

Paclitaxel Delivered as a 3-hr Infusion with Cisplatin in Patients with Gynecologic Cancers: Unexpected Incidence of Neurotoxicity

By Connelly E.   Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 166-168

Academic Press

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers

By Jiko Mari   Yano Ikuko   Sato Eriko   Takahashi Kazushige   Motohashi Hideyuki   Masuda Satohiro   Okuda Masahiro   Ito Noriyuki   Nakamura Eijiro   Segawa Takehiko   Kamoto Toshiyuki   Ogawa Osamu   Inui Ken-ichi  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 284-290

Springer Publishing Company

Access to resources Recommend Favorite